We provide you with 20 years of free, institutional-grade data for HOTH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HOTH. Explore the full financial landscape of HOTH stock.
| Reported Date | CIK | Ticker | Type |
|---|
Hoth Therapeutics, Inc(NASDAQ:HOTH) 
Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topic...
Website: http://www.hoththerapeutics.com
Founded: 2017
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about HOTH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.